Background—Surfactant protein type B (SPB) is needed for alveolar gas exchange. SPB is increased in the plasma of patients with heart failure (HF), with a concentration that is higher when HF severity is highest. The aim of this study was to evaluate the relationship between plasma SPB and both alveolar-capillary diffusion at rest and ventilation versus carbon dioxide production during exercise. Methods and Results—Eighty patients with chronic HF and 20 healthy controls were evaluated consecutively, but the required quality for procedures was only reached by 71 patients with HF and 19 healthy controls. Each subject underwent pulmonary function measurements, including lung diffusion for carbon monoxide and membrane diffusion capacity, and maximal cardiopulmonary exercise test. Plasma SPB was measured by immunoblotting. In patients with HF, SPB values were higher (4.5 [11.1] versus 1.6 [2.9], P 0.0006, median and 25th to 75th interquartile), whereas lung diffusion for carbon monoxide (19.7 4.5 versus 24.6 6.8 mL/mm Hg per min, P 0.0001, mean SD) and membrane diffusion capacity (28.9 7.4 versus 38.7 14.8, P 0.0001) were lower. Peak oxygen consumption and ventilation/carbon dioxide production slope were 16.2 4.3 versus 26.8 6.2 mL/kg per min (P 0.0001) and 29.7 5.9 and 24.5 3.2 (P 0.0001) in HF and controls, respectively. In the HF population, univariate analysis showed a significant relationship between plasma SPB and lung diffusion for carbon monoxide, membrane diffusion capacity, peak oxygen consumption, and ventilation/carbon dioxide production slope (P 0.0001 for all). On multivariable logistic regression analysis, membrane diffusion capacity ( , 0.54; SE, 0.018; P 0.0001), peak oxygen consumption ( , 0.53; SE, 0.036; P 0.004), and ventilation/carbon dioxide production slope ( , 0.25; SE, 0.026; P 0.034) were independently associated with SPB. Conclusion—Circulating plasma SPB levels are related to alveolar gas diffusion, overall exercise performance, and efficiency of ventilation showing a link between alveolar-capillary barrier damage, gas exchange abnormalities, and exercise performance in HF

Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure / D. Magrì, M. Brioschi, C. Banfi, J.P. Schmid, P. Palermo, M. Contini, A. Apostolo, M. Bussotti, E. Tremoli, S. Sciomer, G. Cattadori, C. Fiorentini, P. Agostoni. - In: CIRCULATION. HEART FAILURE. - ISSN 1941-3289. - 2:3(2009), pp. 175-180.

Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure

M. Brioschi;C. Banfi;E. Tremoli;G. Cattadori;C. Fiorentini;P. Agostoni
2009

Abstract

Background—Surfactant protein type B (SPB) is needed for alveolar gas exchange. SPB is increased in the plasma of patients with heart failure (HF), with a concentration that is higher when HF severity is highest. The aim of this study was to evaluate the relationship between plasma SPB and both alveolar-capillary diffusion at rest and ventilation versus carbon dioxide production during exercise. Methods and Results—Eighty patients with chronic HF and 20 healthy controls were evaluated consecutively, but the required quality for procedures was only reached by 71 patients with HF and 19 healthy controls. Each subject underwent pulmonary function measurements, including lung diffusion for carbon monoxide and membrane diffusion capacity, and maximal cardiopulmonary exercise test. Plasma SPB was measured by immunoblotting. In patients with HF, SPB values were higher (4.5 [11.1] versus 1.6 [2.9], P 0.0006, median and 25th to 75th interquartile), whereas lung diffusion for carbon monoxide (19.7 4.5 versus 24.6 6.8 mL/mm Hg per min, P 0.0001, mean SD) and membrane diffusion capacity (28.9 7.4 versus 38.7 14.8, P 0.0001) were lower. Peak oxygen consumption and ventilation/carbon dioxide production slope were 16.2 4.3 versus 26.8 6.2 mL/kg per min (P 0.0001) and 29.7 5.9 and 24.5 3.2 (P 0.0001) in HF and controls, respectively. In the HF population, univariate analysis showed a significant relationship between plasma SPB and lung diffusion for carbon monoxide, membrane diffusion capacity, peak oxygen consumption, and ventilation/carbon dioxide production slope (P 0.0001 for all). On multivariable logistic regression analysis, membrane diffusion capacity ( , 0.54; SE, 0.018; P 0.0001), peak oxygen consumption ( , 0.53; SE, 0.036; P 0.004), and ventilation/carbon dioxide production slope ( , 0.25; SE, 0.026; P 0.034) were independently associated with SPB. Conclusion—Circulating plasma SPB levels are related to alveolar gas diffusion, overall exercise performance, and efficiency of ventilation showing a link between alveolar-capillary barrier damage, gas exchange abnormalities, and exercise performance in HF
chronic heart failure ; surfactant protein B ; lung diffusion ; cardiopulmonary exercise test ; alveolar-capillary barrier damage
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Settore BIO/14 - Farmacologia
2009
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/73349
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 30
social impact